Minor
TibuSHIELD · Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense
Primary completion date changed from estimate of Nov 2026 to Sep 18, 2026
Zura Bio IncPhase 2 NCT06993610 Registry history of NCT06993610 on ClinicalTrials.gov (opens the registry)